Fight Kids Cancer is dedicating its 2025–2026 call (opening 1 September 2025) exclusively to clinical and translational research in paediatric bone and soft tissue sarcomas. Sarcomas remain among the leading causes of cancer-related death in children, yet treatments have stagnated over the past 40 years. This targeted call offers flexible funding and durations to catalyse impactful, resource-efficient projects across Europe.
Eligibility Criteria:
-
Teams based at European academic, clinical or research institutions.
-
Projects must focus on paediatric bone or soft tissue sarcoma.
-
Both clinical trial and translational research proposals welcome.
-
Multidisciplinary, pan-European collaborations encouraged.
Funding Details:
-
Clinical trials: up to 5 EUR million over 5 years.
-
Clinical trial preparation grants: up to 250,000 EUR over 2 years.
-
Translational research: up to 2 EUR million over 4 years.
Call Timeline:
-
Call Opens: 1 September 2025.
-
Expression of Interest Deadline: 17 October 2025, 12:00 CEST.
-
Full Proposal Phase Opens: early January 2026.
-
Full Proposal Deadline: 6 March 2026, 12:00 CET.
-
Rebuttal Phase: 28 April – 5 May 2026.
How to Apply:
- Submit your Expression of Interest by 17 October 2025 at 12:00 CEST.
- If invited, prepare and submit your Full Proposal using the provided template by 6 March 2026 at 12:00 CET.
Contact & Support:
Email: [email protected]